Literature DB >> 18716361

Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) study.

Minako Terai1, Mitsuru Ohishi, Norihisa Ito, Takashi Takagi, Yuji Tatara, Masaharu Kaibe, Norio Komai, Hiromi Rakugi, Toshio Ogihara.   

Abstract

Increased arterial stiffness and impaired vasodilator response have been associated with cardiovascular events in high-risk patients. However, whether arterial changes predict the occurrence of hypertensive complications is still unclear. Therefore, we designed a hospital-based cohort study to examine the prognostic impact of arterial functional changes on stroke and cardiovascular diseases in hypertensive patients. The study employed 676 patients with essential hypertension. At baseline, we evaluated second-derived photoplethysmography, carotid-femoral pulse wave velocity (PWV), and forearm reactive hyperemia. We classified subjects into quartile groups according to the baseline measurements of these evaluations and assessed the ability of each measure to predict stroke and cardiovascular diseases (CVD). During a mean follow-up period of 57 months, 52 strokes, 40 CVD, and 22 deaths were recorded. Kaplan-Meier analysis revealed that patients in the highest quartile of PWV showed a higher frequency of stroke and CVD (p<0.0001) and total mortality (p=0.0016), and those in the highest quartile of reactive hyperemia showed a lower frequency of stroke and CVD (p=0.0415). A Cox hazard model identified that classification in the highest quartile of PWV (relative risk=2.717) and reactive hyperemia (0.416) were predictive of stroke and CVD after adjustment for other risk factors. In subjects who did not experience stroke or CVD before the study period (n=558), only PWV was related with the occurrence of stroke and CVD based on the Cox hazard model. In conclusion, increased aortic stiffness evaluated by PWV is more prognostic of cardiovascular events in hypertensive patients than several non-invasive atherosclerotic evaluations.

Entities:  

Mesh:

Year:  2008        PMID: 18716361     DOI: 10.1291/hypres.31.1135

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  21 in total

1.  Doppler ultrasound in the measurement of pulse wave velocity: agreement with the Complior method.

Authors:  Jordi Calabia; Pere Torguet; Maria Garcia; Isabel Garcia; Nadia Martin; Bernat Guasch; Diana Faur; Martí Vallés
Journal:  Cardiovasc Ultrasound       Date:  2011-04-15       Impact factor: 2.062

2.  Aortic pulse wave velocity is associated with measures of subclinical target organ damage.

Authors:  Thais Coutinho; Stephen T Turner; Iftikhar J Kullo
Journal:  JACC Cardiovasc Imaging       Date:  2011-07

3.  Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients.

Authors:  Murat H Sipahioglu; Hamit Kucuk; Aydin Unal; Mehmet G Kaya; Fatih Oguz; Bulent Tokgoz; Oktay Oymak; Cengiz Utas
Journal:  Perit Dial Int       Date:  2011-03-31       Impact factor: 1.756

4.  Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Authors:  Kristen A Baltgalvis; Kathy White; Wei Li; Mark D Claypool; Wayne Lang; Raniel Alcantara; Baljit K Singh; Annabelle M Friera; John McLaughlin; Derek Hansen; Kelly McCaughey; Henry Nguyen; Ira J Smith; Guillermo Godinez; Simon J Shaw; Dane Goff; Rajinder Singh; Vadim Markovtsov; Tian-Qiang Sun; Yonchu Jenkins; Gerald Uy; Yingwu Li; Alison Pan; Tarikere Gururaja; David Lau; Gary Park; Yasumichi Hitoshi; Donald G Payan; Todd M Kinsella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

5.  Prognostic impact of regional arterial stiffness in hypertensive patients.

Authors:  Tatsuo Kawai; Mitsuru Ohishi; Miyuki Onishi; Norihisa Ito; Yasushi Takeya; Ryosuke Oguro; Yoichi Takami; Koichi Yamamoto; Hiromi Rakugi
Journal:  Heart Vessels       Date:  2014-02-25       Impact factor: 2.037

Review 6.  Arterial stiffness and increased cardiovascular risk in chronic kidney disease.

Authors:  Yuxia Ma; Lin Zhou; Jinghui Dong; Xiaoshen Zhang; Shi Yan
Journal:  Int Urol Nephrol       Date:  2015-05-20       Impact factor: 2.370

7.  Subclinical Vascular Disease in Children With Human Immunodeficiency Virus in Uganda Is Associated With Intestinal Barrier Dysfunction.

Authors:  Sahera Dirajlal-Fargo; Zainab Albar; Emily Bowman; Danielle Labbato; Abdus Sattar; Christine Karungi; Chris T Longenecker; Rashida Nazzinda; Nicholas Funderburg; Cissy Kityo; Victor Musiime; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2020-12-15       Impact factor: 9.079

8.  Effect of five nights of sleep extension on peripheral vascular function: a randomized crossover investigation into long sleep duration.

Authors:  Joaquin U Gonzales; Cayla Clark; Todd Anderson
Journal:  Sleep Med       Date:  2022-02-02       Impact factor: 3.492

Review 9.  Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects.

Authors:  Yoav Ben-Shlomo; Melissa Spears; Chris Boustred; Margaret May; Simon G Anderson; Emelia J Benjamin; Pierre Boutouyrie; James Cameron; Chen-Huan Chen; J Kennedy Cruickshank; Shih-Jen Hwang; Edward G Lakatta; Stephane Laurent; João Maldonado; Gary F Mitchell; Samer S Najjar; Anne B Newman; Mitsuru Ohishi; Bruno Pannier; Telmo Pereira; Ramachandran S Vasan; Tomoki Shokawa; Kim Sutton-Tyrell; Francis Verbeke; Kang-Ling Wang; David J Webb; Tine Willum Hansen; Sophia Zoungas; Carmel M McEniery; John R Cockcroft; Ian B Wilkinson
Journal:  J Am Coll Cardiol       Date:  2013-11-13       Impact factor: 24.094

Review 10.  Metabolic complications and treatment of perinatally HIV-infected children and adolescents.

Authors:  Linda Barlow-Mosha; Allison Ross Eckard; Grace A McComsey; Philippa M Musoke
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.